Uracil compounds as P2-purinoreceptor 7-transmembrane G-protein coupled receptor antagonists
申请人:AstraZeneca UK Limited
公开号:US06218376B1
公开(公告)日:2001-04-17
Compounds of formula I or salts thereof
where for example Y is a group of the formula (i)
and R1 is a group of formula (ii)
are provided along with compositions containing them and processes for their preparation. The compounds are P2-purinoreceptor 7-transmembrane G-protein coupled receptor antagonists, and are useful in the treatment of inflammatory conditions.
提供了具有公式I或其盐的化合物,其中例如Y是公式(i)的基团,R1是公式(ii)的基团,以及含有它们的组合物和其制备方法。这些化合物是P2-嘌呤受体7-跨膜G蛋白偶联受体拮抗剂,可用于治疗炎症症状。